Diebold Nixdorf, Incorporated
DBD
$61.70
$1.692.82%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.86% | -3.75% | -2.66% | -0.25% | 2.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.86% | -3.75% | -2.66% | -0.25% | 2.88% |
| Cost of Revenue | -3.93% | -5.86% | -4.98% | -2.81% | 1.51% |
| Gross Profit | 0.43% | 3.04% | 4.91% | 8.17% | 7.34% |
| SG&A Expenses | 0.70% | 0.22% | -8.50% | -12.17% | -15.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -292.31% | -450.00% | -287.50% | -188.46% | -- |
| Total Operating Expenses | -3.32% | -4.81% | -5.64% | -4.67% | -2.07% |
| Operating Income | 2.69% | 10.63% | 52.07% | 106.07% | 165.87% |
| Income Before Tax | 19.73% | -98.77% | -96.25% | -96.57% | -95.47% |
| Income Tax Expenses | -69.11% | -64.91% | 26.60% | -15.06% | -46.65% |
| Earnings from Continuing Operations | 2,565.00% | -100.47% | -100.54% | -101.05% | -99.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -50.00% | -75.00% | -46.67% | -300.00% | -162.07% |
| Net Income | 25,200.00% | -100.60% | -100.69% | -101.20% | -99.98% |
| EBIT | 2.69% | 10.63% | 52.07% | 106.07% | 165.87% |
| EBITDA | 2.94% | 6.75% | 31.74% | 61.54% | 81.17% |
| EPS Basic | 25,496.30% | -100.89% | -100.92% | -101.55% | -99.98% |
| Normalized Basic EPS | -3.94% | 11.03% | 322.20% | 1,001.35% | 333.52% |
| EPS Diluted | 124,100.00% | -100.91% | -100.95% | -101.59% | -100.00% |
| Normalized Diluted EPS | -4.56% | 10.88% | 320.92% | 1,004.12% | 333.54% |
| Average Basic Shares Outstanding | -1.00% | -11.64% | -29.11% | -40.75% | -49.08% |
| Average Diluted Shares Outstanding | -0.53% | -11.85% | -29.27% | -40.86% | -49.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |